The commercial landscaping giant's latest quarterly results, featuring a widening net loss despite modest revenue growth, cast doubt on the efficacy of its ongoing 'One BrightView' strategic overhaul and sparked a sharp sell-off.
Merck & Co. saw its stock rise over 2% following a solid quarterly earnings report, even as its full-year guidance came in softer than some expected. CNBC's Jim Cramer highlighted the pharmaceutical giant as a top pick in the sector, pointing to underlying strength beyond the headline numbers.
Oracle's ambitious plan to raise up to $50 billion for a massive AI infrastructure expansion has rattled investors, sending its stock down sharply. While the move underscores its commitment to competing with cloud leaders, concerns over execution risk and debt levels are taking center stage.
Fabrinet (FN) reported robust fiscal Q2 2026 results, beating estimates with revenue of $1.13B and issuing upbeat guidance. However, the stock fell sharply as investors weighed aggressive expansion plans against high expectations and execution risks.
The Danish pharmaceutical giant forecasts a potential double-digit sales decline for the year, citing pricing pressures and intensifying competition in the lucrative GLP-1 drug market.
A new AI tool from Anthropic sparked a broad sell-off in tech stocks, dragging down sector leader Nvidia. CEO Jensen Huang pushed back against fears of software obsolescence, calling the market reaction 'illogical'.
TerraCom Limited's non-executive chairman has significantly increased his investment in the company, signaling insider confidence as the coal miner navigates a challenging market.
A deep-dive valuation analysis suggests Cochlear Limited's current market price may be stretched. Using a discounted cash flow model, we find a significant gap between the calculated fair value and the trading price, raising questions for investors.
A significant insider sale at Applied Digital, a key player in AI infrastructure, sparks debate among investors as the stock rides a wave of sector enthusiasm and soaring valuations.
Defense giant Lockheed Martin reported better-than-expected fourth-quarter results, reaffirmed its 2026 outlook, and secured a key $328.5 million sensor contract for Taiwan's Air Force, driving its stock higher. Analysts point to a record $194 billion order backlog as a buffer, though questions linger about valuation and long-term budget dependencies.
In a moving video released for World Cancer Day, Catherine, Princess of Wales, opens up about her own experience with the disease, offering a message of hope and connection to others on similar paths, as King Charles also reflects on his recovery.
A proposed acquisition of eye-lens maker STAAR Surgical by Alcon faces fierce resistance from major investors, who argue the company is being sold at a cyclical low. The clash has forced deal amendments and delays, setting the stage for a potential proxy fight or higher bid.
Boston Scientific's robust Q4 results were overshadowed by investor disappointment over its forward guidance, triggering a sharp sell-off and raising questions about market expectations for high-flying medtech stocks.
Wolverine Asset Management significantly reduced its position in Lucid Group during Q4 2025, a move that raises questions about the luxury EV maker's financial trajectory and competitive standing as it launches its crucial Gravity SUV.
Sonos stock rallied nearly 5% following a quarterly earnings beat, driven by aggressive cost management. However, a sharp 26% reduction in R&D spending raises questions about the audio company's competitive future amidst a profitable but potentially innovation-starved present.
Cloud communications firm 8x8 (EGHT) surged over 43% after posting Q4 results that handily topped analyst forecasts, fueled by robust demand for its AI-powered customer experience platform and an upbeat revenue outlook.
MGM Resorts International stock surged more than 11% after its sports betting joint venture, BetMGM, reported a dramatic swing to profitability and issued a bullish forecast, signaling a major inflection point for the digital venture.
The New York Times Company saw its stock plunge more than 8% Thursday after a mixed fourth-quarter earnings report, where disappointing profitability figures and slowing subscriber additions overshadowed better-than-expected revenue.
Sonos stock climbed over 4% after the audio specialist's latest earnings report showcased a dramatic expansion in profitability, significantly exceeding Wall Street forecasts despite flat year-over-year revenue.
Azenta's stock tumbled sharply after its Q4 results revealed a significant shortfall in a key profitability metric, despite revenue meeting expectations, sparking a major sell-off.
